Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage ...

Researchers have developed an AI system called Dr. CaBot that spells out its reasoning as it works through challenging medical cases and reaches a diagnosis. For the first time, the New England ...

Background Atrial fibrillation (AF) is linked to significant morbidity and mortality, with ischaemic stroke being a leading ...

A decentralized model for the screening and management of MDR/RR-TB contacts implemented by trained CHWs has wider potential ...

Combined testing uptake (HCV RDT or HCV RDT/RNA) was higher for the community-based strategy than for the facility-based ...

As they explained in their case report in the Journal of Neurology and Neuroscience, ophthalmologic examination identified ...

Neutra, a naturalized American citizen who emigrated from Austria, was instrumental in creating Southern California’s midcentury-modern design aesthetic, while the Case Study Houses, a program ...

Artificial intelligence-enabled medical devices with no clinical validation were more likely to be the subject of recalls, according to a study published in JAMA Health Forum. The study, published on ...

A research team at Saarland University has demonstrated in a clinical study that a widely used anti-allergy nasal spray containing the active ingredient azelastine can significantly reduce the risk of ...

Background Few data regarding the incidence and outcomes of acute hypoxaemic respiratory failure (AHRF) in low- and middle-income countries exist. Methods We undertook a prospective, observational ...

The companies that are succeeding with in-house AI, however, have seen revenue jump from zero to $20 million in a year. U.S. businesses have invested between $35 billion and $40 billion into internal ...